文献速递中医康复中医内科中药与中成药合理使用

PRIMIER 队列:整合医学真实世界疗效评估

Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: Outcomes of the PRIMIER cohort.
PubMed 文献 · Complement Ther Med · 2022-11-23

4883 人开始评估,3658 人完成基线,2374 人(65%)完成至少 1 次随访并有电子健康记录和至少 1 次整合医学就诊。12 个月时所有 PROMIS-29 指标、PSS-4 与 PAM 均显著改善(p < 0.001),PROMIS-29 心理与身体健康摘要评分分别有 38% 和 28% 达到临床意义改善。

要点

  • 12 个月时 PROMIS-29 各维度、PSS-4 与 PAM 均显著改善(p < 0.001)。
  • PROMIS-29 心理与身体健康摘要评分临床意义改善率分别为 38% 和 28%。
  • 该研究为整合医学真实世界疗效评估中规模最大者。

核心结论

  • 整合医学治疗在 12 个月时使生活质量、感知压力与患者激活度均出现统计学和临床改善。

研究设计与样本

  • 前瞻性、纵向、观察性研究,评估患者报告结局。
  • 4883 人开始评估,3658 人完成基线指标,2374 人(65%)完成至少 1 次随访并有电子健康记录和至少 1 次整合医学就诊。
  • 采用线性混合效应模型检验指标从基线至 12 个月的变化。

主要发现

  • 12 个月时所有 PROMIS-29 指标、PSS-4 与 PAM 均显著改善(p < 0.001)。
  • 12 个月时 PROMIS-29 心理与身体健康摘要评分分别有 38% 和 28% 达到临床意义改善。
  • 参与者平均年龄 51.4 岁,白人占 88.4%,女性占 79.7%,大学教育程度占 78.5%。

临床怎么用

  • 可将 PROMIS-29、PSS-4 与 PAM 用于整合医学门诊患者生活质量和压力等的纵向随访评估。
  • 临床解读时应关注 12 个月时心理与身体健康摘要评分的临床意义改善比例。

局限性

  • 为观察性研究,未设对照,无法推断因果。
  • 样本以白人、女性、大学教育程度者为主,外推需谨慎。
  • 仅 65% 的基线完成者纳入随访分析,存在失访偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the real-world effectiveness of integrative medicine treatment on quality of life using the Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER). DESIGN: A prospective, longitudinal, observational evaluation of patient reported outcomes for quality of life. SETTING: Participants were patients from 17 integrative medicine clinics who received personalized, integrative medicine treatments between August 2013 and October 2017. MAIN OUTCOME MEASURES: Participants completed the Patient Reported Outcomes Measurement Information System (PROMIS)- 29, Perceived Stress Scale-4 (PSS-4), and the Patient Activation Measure (PAM) at index (baseline) visit and at 2, 4, 6, and 12 month follow-up assessments. Electronic health record data included diagnostic and billing codes/descriptions. A linear mixed-effects model was used to test whether outcomes changed from index through 12 months RESULTS: During enrollment, 4883 participants began the assessment, 3658 completed the index measures, and 2374 (65 %) completed at least 1 follow-up assessment, had electronic health record data and at least 1 integrative medicine visit. Most participants (mean age=51.4 years) were white (88.4 %), female (79.7 %), and college-educated (78.5 %). Significant improvements (p < 0.001) were observed at 12-months on all PROMIS-29 measures, PSS-4, and PAM. At 12 months, clinically meaningful improvements were found for 38 % and 28 % on PROMIS-29 Mental and Physical Health Summary scores respectively. CONCLUSIONS: PRIMIER is the largest study to assess the real-world effectiveness of integrative medicine. Results indicate a statistical and clinical improvement across all measures at 12 months. Future research could explore whether dosing, timing or combinations of integrative medicine interventions have differential impacts on quality of life.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Dusek JA, Gao Q, Kim RS, et al. Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: Outcomes of the PRIMIER cohort. Complement Ther Med. 2022. PMID: 36435299. doi:10.1016/j.ctim.2022.102904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。